Drug overdose deaths have taken thousands of lives in the last roughly 25 years in Maine, also having ripple effects on the loved ones of those who died.
opioid epidemic
Maine’s sixth annual Opioid Response Summit draws hundreds to Auburn
Gov. Janet Mills thinks the enhanced prescription monitoring program is one of the factors that brought down the number of drug overdose deaths last year.
Drug overdose deaths in Maine continue to decline after plummeting in 2023
The state is on track for a 9.8% decline in 2024 from the previous year, after seeing a 16% decrease in 2023.
In rural Maine, efforts to provide drug treatment often met with resistance, despite high demand
Only about 2,400 people live in the Lincoln County town of Whitefield, where a 54-bed recovery residence recently opened in spite of heavy opposition.
The Supreme Court rejected an opioid settlement that could have brought Maine $20 million. What now?
While the parties will now have to renegotiate a new settlement, Maine is expecting to receive about $235 million over the next 18 years from other opioid settlements.
Supreme Court rejects nationwide opioid settlement with OxyContin maker Purdue Pharma
The settlement would have shielded Sackler family members who own the company from civil lawsuits over the toll of opioids but also would’ve provided billions of dollars to combat the epidemic.
Mobile medical team aims to reduce overdose deaths in Greater Portland
The van is operated by Greater Portland Health, which serves vulnerable communities in Portland, South Portland and Westbrook.
Fewer Maine babies are being born with substance exposure. No one’s sure why
Hospital data show the lowest figures in a decade, but officials say changes in reporting could be skewing the results.
Maine records one of nation’s biggest declines in overdose deaths
Maine, which reported a 16% drop, is one of four states that saw at least a 15% decline in fatal drug overdoses in 2023.
Madison residents, officials object to planned clinic offering methadone
Acadia Healthcare is under contract to buy 2 Old Point Ave., the former Taylor’s Drug Store, where it plans to open a behavioral health clinic offering medication-assisted treatment and other services.